Genetec Technology Bhd

Genetec Technology Bhd maintains a strong liquidity position, with a current ratio of 4.7 and cash and equivalents amounting to MYR 64.5 million, which is significantly higher than the industry median. The company's liquidity FPT score indicates a low risk of liquidity stress, supported by a free cash flow of MYR 17.4 million and a debt-to-equity ratio of 0.07, suggesting a conservative capital structure.

Profitability metrics show a return on equity of 3.54% and a return on assets of 2.85%, which are below the industry median for industrial machinery firms. The company's operating margin is 29.5%, calculated from operating income of MYR 20.8 million on revenue of MYR 70.5 million, indicating room for improvement in cost management and pricing power.

The company's revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, such as demand fluctuations in the semiconductor and electronics manufacturing industries.

Looking ahead, Genetec Technology Bhd is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The company's capital expenditure of MYR -24.6 million suggests a focus on asset optimization rather than expansion, which aligns with its current financial position.

Risk factors for Genetec Technology Bhd are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is also low, as there are no signs of imminent share issuance or dilutive events. The absence of significant debt and the presence of substantial cash reserves further mitigate financial risk.

Recent events, including analyst estimates and recommendations, indicate a mixed outlook. The mean price target is MYR 0.55, with a median of MYR 0.70, and the mean recommendation score is 3.33, suggesting a neutral stance from analysts. There are no strong buy recommendations, with only one buy and no hold ratings reported.

Operating and net margins significantly exceed the industrial machinery cohort median, indicating superior profitability relative to peers.

Analysts project 78.5% upside to the mean price target, suggesting significant undervaluation relative to current market price.

The company maintains a low debt-to-equity ratio of 0.07, well below the cohort median of 0.20.

Cash conversion efficiency ranks in the top quartile of the cohort, outperforming the median significantly.

Risk flags for dilution, liquidity, and credit are all assessed as low, indicating a stable risk profile.

The company reported a net loss of MYR 31.4 million in FY2025, reversing previous profitability trends.

Free cash flow turned negative at MYR 56.5 million in FY2025, a significant deterioration from prior periods.

Long-term debt increased to MYR 32.2 million in FY2025, up from MYR 22.7 million in the prior year.

Return on equity of 3.54% falls slightly below the industrial machinery cohort median of 3.56%.

Revenue MYR 222.7M, −35,8% YoY; Operating income −127,2% YoY.

• ▍Revenue MYR 222.7M, −35,8% YoY
• ▍Operating income −127,2% YoY
• ▍Net income −136,4% YoY
• ▍Net margin -14.1%

Revenue MYR 347.0M, +17,8% YoY; Operating income +16,3% YoY.

• ▍Revenue MYR 347.0M, +17,8% YoY
• ▍Operating income +16,3% YoY
• ▍Net income +29,2% YoY
• ▍Net margin 24.8%